IRIXのニュース
IRIDEX (IRIX) Investor Presentation - Slideshow 2023/03/29 12:32:58 Seeking Alpha
The following slide deck was published by IRIDEX Corporation in conjunction with this event.
Iridex''s Return On Capital Employed Insights 2023/03/14 14:48:36 Benzinga
According to Benzinga Pro data, during Q4, Iridex (NASDAQ: IRIX ) posted sales of $15.20 million. Earnings were up 35.03%, but Iridex still reported an overall loss of $1.15 million. Iridex collected $14.63 million in revenue during Q3, but reported earnings showed a $1.77 million loss. Why Is ROCE Significant? Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a … Full story available on Benzinga.com
IRIDEX Corp PT Lowered to $6.25 at Roth/MKM 2023/03/10 11:36:02 Investing.com
https://www.investing.com/news/pro/iridex-corp-pt-lowered-to-625-at-rothmkm-432SI-3027418
IRIDEX Corporation (IRIX) Q4 2022 Earnings Call Transcript 2023/03/10 03:12:04 Seeking Alpha
IRIDEX Corporation (NASDAQ:NASDAQ:IRIX) Q4 2022 Earnings Conference Call March 9, 2023 5:00 PM ETCompany ParticipantsPhilip Taylor - Investor Relations, Gilmartin GroupDavid Bruce -…
Iridex: Q4 Earnings Snapshot 2023/03/09 21:55:24 WTOP
MOUNTAIN VIEW, Calif. (AP) — MOUNTAIN VIEW, Calif. (AP) — Iridex Corp. (IRIX) on Thursday reported a loss of $1.1…
IRIDEX Corp PT Lowered to $8.25 at Roth Capital 2022/11/15 08:32:06 Investing.com
https://www.investing.com/news/pro/iridex-corp-pt-lowered-to-825-at-roth-capital-432SI-2944238
Iridex stock rises after reporting Q3 results beat, reaffirming FY 2022 guidance 2022/11/11 19:01:44 Seeking Alpha
Shares of micro-cap eye-lasers procedure company Iridex (IRIX) rose as much as 11.4% to $2.25 in Friday afternoon trading, after it reported a Q3 results beat and reaffirmed its FY…
IRIDEX Corporation (IRIX) Q3 2022 Earnings Call Transcript 2022/11/11 03:11:03 Seeking Alpha
IRIDEX Corporation (NASDAQ:NASDAQ:IRIX) Q3 2022 Results Conference Call November 10, 2022 05:00 PM ET Company Participants David Bruce - Chief Executive Officer Fuad Ahmad - Interim Chief…
UBX, ACDC and EXFY are among after hour movers 2022/11/10 23:03:30 Seeking Alpha
Gainers: IRIDEX (IRIX) +14%. Matterport (MTTR) +12%
IRIDEX Earnings, Revenue Beat in Q3 By Investing.com 2022/11/10 22:36:00 Investing.com
IRIDEX Earnings, Revenue Beat in Q3
Iridex''s Cyclo G6 platform for treating glaucoma gets regulatory clearance in China 2022/06/14 14:02:34 Seeking Alpha
Iridex (IRIX) on Tuesday said it had got Chinese regulatory clearance to market and sell its Cyclo G6 platform for the treatment of glaucoma diseases.IRIX and its distribution…
Iridex Obtains Regulatory Clearance for Cyclo G6® Glaucoma Platform in China 2022/06/14 13:21:00 GlobeNewswire
MOUNTAIN VIEW, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced that it has received regulatory clearance to market and sell its Cyclo G6 ® platform for the treatment of glaucoma diseases in China by its National Medical Products Administration (NMPA). In accordance with the clearance, Iridex and distribution partners Topcon and Clinico will launch the Cyclo G6 system and related probes in China beginning in the third quarter of 2022.
Iridex Obtains Regulatory Clearance for Cyclo G6 Glaucoma Platform in China 2022/06/14 13:21:00 Wallstreet:Online
MOUNTAIN VIEW, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced that it has received regulatory clearance to market and sell its Cyclo G6 platform for the treatment of glaucoma diseases in China by its National Medical Products Administration
Rate - IRIDEX Stock Rating Upgraded by Zacks Investment Research 2022/06/02 06:09:08 Business Mag
IRIDEX was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports. According to Zacks…
IRIDEX Corporation''s (IRIX) CEO David Bruce on Q1 2022 Results - Earnings Call Transcript 2022/05/13 02:06:05 Seeking Alpha
IRIDEX Corporation (NASDAQ:NASDAQ:IRIX) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants David Bruce – Chief Executive Officer Hunter Cabi – Investor Relations…